• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Neuravi Limited

Johnson & Johnson hosts launch party for Cerenovus neurovascular biz

September 7, 2017 By Fink Densford

Johnson & Johnson (NYSE:JNJ) said today it launched its Cerenovus brand, which combined its Pulsar Vascular and Neuravi acquisitions and its remaining Codman Neuro neurological portfolio. Cerenovus was launched at the European Society of Minimally Invasive Neurological Therapy’s 9th annual meeting, J&J said. Johnson & Johnson said that the Cerenovus product portfolio aims to help improve stroke care, with the number […]

Filed Under: Business/Financial News, Neurological Tagged With: cerenovus, Johnson and Johnson, Neuravi Limited, Pulsar Vascular

Johnson & Johnson rolls Pulsar Vascular, Neuravi into new Cerenovus neurovascular biz

July 25, 2017 By Brad Perriello

Updated to clarify that J&J’s existing Codman Neuro neurovascular portfolio will also be included in the new Cerenovus business. Johnson & Johnson (NYSE:JNJ) said yesterday that it’s medical device division is rolling the Pulsar Vascular and Neuravi acquisitions, as well as its existing Codman Neuro neurological portfolio, into a new neurovascular business dubbed Cerenovus. The […]

Filed Under: Mergers & Acquisitions, Neurological, Surgical, Wall Street Beat Tagged With: cerenovus, Codman Neuro, Johnson and Johnson, Neuravi Limited, Pulsar Vascular

Codman Neuro acquires Neuravi

April 10, 2017 By Fink Densford

Johnson & Johnson (NYSE:JNJ) business unit Codman Neuro said today it acquired Neuravi and its portfolio of neurovascular therapy technology for an undisclosed amount. Neuravi produces the EmboTrap and EmboTrap II revascularization platforms designed capture clots and allow blood flow to resume immediately after the clot has been secured in patients who have experienced a stroke. J&J’s Codman Neuro […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Neurological Tagged With: Codman Neuro, Neuravi Limited

Neuravi raises $16.7m

November 2, 2016 By Fink Densford

Neuravi said today it raised $16.7 million (EU €15 million) in a new round of debt financing, with funds slated to support U.S. commercialization and portfolio expansion. Money in the round came from healthcare alternative financing provider IPF Partners, the Galway, Ireland-based company said. Funds raised in the round will be invested into the U.S. commercialization […]

Filed Under: Blood Management, Business/Financial News, Vascular Tagged With: Neuravi Limited

Neuravi wins CE Mark for EmboTrap II stent retriever

September 8, 2016 By Fink Densford

Neuravi said today it won CE Mark approval in the European Union for its EmboTrap II stent retriever and revascularization device. The device is a next-gen version of the company’s EmboTrap, and is designed to treat a broader range of clots with sizes that are deliverable through a 0.021″ microcatheter. “The EmboTrap platform has been a […]

Filed Under: Blood Management, Regulatory/Compliance, Vascular Tagged With: Neuravi Limited

Neuravi launches clinical trial of Embotrap stent retriever

November 5, 2015 By Fink Densford

Neuravi said today it enrolled the 1st patient in a clinical trial of its novel EmboTrap revascularization stent retriever device for treating acute ischemic stroke. Data from the study will be submitted as part of Neuravi’s FDA premarket approval application, the Ireland-based company said. “Working to improve clinical outcomes in stroke is central to Neuravi’s mission, […]

Filed Under: Clinical Trials, Surgical, Vascular Tagged With: Neuravi Limited

Neuravi launches EmboTrap in Europe

October 1, 2015 By Fink Densford

Neuravi said today it launched its EmboTrap minimally invasive thrombectomy device for the treatment of acute ischemic stroke in Europe. The Embotrap device functions by capturing clots and allowing blood flow to resume immediately after the clot has been secured in patients who have experienced a stroke, CEO Eamon Brady told MassDevice.com in an interview in June. […]

Filed Under: Blood Management, Cardiovascular, Catheters, Stents, Vascular Tagged With: Neuravi Limited

Neuravi raises $21m Series B for thrombectomy device

June 17, 2015 By Fink Densford

Neuravi said today that it raised $21 million in a Series B  round for its Embotrap minimally invasive thrombectomy device. “The intention of the funding round is to launch the device in Europe, to run the Arise program for the U.S., to attempt to bring the device for U.S. approval and to continue to develop further […]

Filed Under: Blood Management, Business/Financial News, Cardiovascular, Catheters, Stents Tagged With: Life Sciences Partners, Neuravi Limited

Neuravi closes $6.5M round for clot retrieval | Funding Roundup

July 11, 2012 By MassDevice staff Leave a Comment

Funding Roundup

 Neuravi successfully completes Series A financing

Irish medical device company Neuravi Limited successfully completed a Series A financing round for $6.5 million (€5.2 million).

Filed Under: Funding Roundup, News Well Tagged With: MicroTransponder Inc., Neuravi Limited, Terumo

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy